In a previous study on head and neck squamous cell carcinoma cells, we reported the influence of the order of treatments with cisplatin and BCH, a canonical LAT1 inhibitor, on their combined effects. The gene discussed is SLC7A5; the disease is head and neck squamous cell carcinoma.